Abstract 6658: Inhibiting glycolysis for the treatment of HGF/MET/TWIST1 driven NSCLC brain metastases
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-6658
Abstract: Non-small cell lung cancer (NSCLC) has the highest incidence of brain metastases (BM), with ∼40% of patients developing BM. We identified a significant enrichment of MET amplification (amp) in NSCLC BM compared to primary lung… read more here.
Keywords: brain; glycolysis; sensitivity; driven nsclc ... See more keywords